WHOOP has raised $575 million in new funding valued at $10.1 billion, accelerating its goal of building a global platform for personalized, preventative healthcare powered by artificial intelligence and biometric data.
The Series G round was led by Collaborative Fund and attracted a broad mix of institutional investors, sovereign wealth funds and leading healthcare companies, including Qatar Investment Authority and Mubadala Investment Company. Strategic support also came from Abbott and Mayo Clinic, underscoring the growing convergence between technology and traditional healthcare systems.
The round also attracted high-profile individual investors from the world of sports and entertainment, including Cristiano Ronaldo, LeBron James and Rory McIlroy, reflecting WHOOP’s strong association with excellence and wellness.
The investment comes at a time when healthcare systems worldwide are under increasing strain due to rising rates of chronic disease and an aging population. WHOOP is positioning itself at the forefront of a shift from reactive treatment to preventive, data-driven health management.
Founder and CEO Will Ahmed said the company is building a platform to help individuals continuously monitor, understand and improve their health.
“We are creating a personal health system that enables people to improve both their performance and their long-term well-being,” he said.
At the heart of the platform is continuous biometric monitoring, combined with AI models trained on more than 24 billion hours of physiological data. This enables WHOOP to provide personalized insights into sleep, recovery, stress and physical performance, as well as early indicators of potential health risks.
WHOOP has experienced strong growth in recent years, with more than 2.5 million members worldwide and bookings growing 103 percent in 2025 to a run rate of $1.1 billion. The company also reported positive operating cash flow during the year, underscoring its financial momentum.
The new financing will support further expansion in key international markets including Europe, the Gulf, Latin America and Asia, as well as continued growth in the United States.
To support this expansion, WHOOP plans to hire more than 600 additional employees worldwide to focus on research, development and product innovation.
The involvement of established healthcare organizations like Abbott signals a broader shift toward integrating consumer technology with clinical expertise.
By combining wearable technology with advanced analytics, WHOOP aims to provide a more holistic view of health, enabling users to make informed decisions about their lifestyle and potentially prevent serious illnesses before they occur.
The platform’s high engagement, with users opening the app multiple times a day, highlights the growing demand for real-time health insights that go beyond traditional fitness tracking.
While WHOOP initially appealed to athletes and elite athletes, the company is now targeting a broader audience, including executives, professionals and consumers who want to optimize both their health and productivity.
There is increasing focus on “healthspan,” the length of time people stay healthy and active, rather than just lifespan.
Cristiano Ronaldo, an investor and ambassador, described the platform as an important tool for managing his own health, reflecting its positioning at the intersection of performance and well-being.
The latest round of funding strengthens WHOOP’s position as one of the most valuable players in the rapidly growing digital health sector.
As advances in AI and data analytics continue to transform healthcare, companies that can combine technology, user engagement and clinical relevance are expected to play a central role in the industry’s future.
For WHOOP, the challenge now is to scale its platform globally while ensuring accuracy, trust and regulatory compliance, and transform wearable data into meaningful, actionable health outcomes at scale.
